Krishna Institute of Medical Sciences CEO, MD, chairman, board of directors and AGM
NSE: KIMSBSE: 543308Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹668.55.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹27,937 Cr285th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 3 Aug 2026
- 136.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 12.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 3 Aug 2026
- 9.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 3 Aug 2026
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 1.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,42,42546.4% delivered
Krishna Institute of Medical Sciences board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorBhaskara Rao Bollineni
- Chief executiveAbhinay Bollineni
- Company Secretary and Compliance OfficerNagajayanthi J.R
9 directors5 independent4 executive
- Bhaskara Rao Bollineni · Chairperson and managing directorExecutive · joined Nov 2002 · reappointed Apr 2022 · 0 months as independent · 2 listed boards · 4 committee seats
- Anitha DandamudiExecutive · joined Mar 2008 · reappointed Apr 2022 · 0 months as independent · 1 listed board
- Abhinay Bollineni · Chief executiveExecutive · joined Jan 2019 · reappointed Jan 2022 · 0 months as independent · 1 listed board · 4 committee seats
- Saumen ChakrabortyIndependent · joined Jan 2021 · reappointed Jan 2024 · 65 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
- Ratna Kishore KazaIndependent · joined Jan 2021 · reappointed Jan 2024 · 65 months as independent · 1 listed board · 1 as independent · 5 committee seats, 1 as chair
- Venkata Ramudu JasthiIndependent · joined Jan 2021 · reappointed Jan 2024 · 65 months as independent · 3 listed boards · 3 as independent · 4 committee seats
- Prameela Rani YalamanchiliIndependent · joined May 2022 · reappointed May 2025 · 49 months as independent · 3 listed boards · 3 as independent · 8 committee seats, 5 as chair
- Suresh Natwarlal PatelIndependent · joined Jan 2025 · reappointed Jan 2025 · 17 months as independent · 1 listed board · 1 as independent · 3 committee seats, 2 as chair
- Adwik BollineniExecutive · joined Nov 2023 · reappointed May 2026 · 0 months as independent · 1 listed board · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 13 Jun 20269 of 9 present5 independent · 28 days in between
- 15 May 20268 of 9 present5 independent · 49 days in between
- 26 Mar 20269 of 9 present5 independent · 14 days in between
- 11 Mar 20268 of 9 present5 independent · 32 days in between
1 earlier meeting
- 6 Feb 20269 of 9 present5 independent
Audit Committee
Chair Saumen Chakraborty
Ratna Kishore Kaza, Prameela Rani Yalamanchili
- 13 Jun 20263 of 3 present3 independent · 28 days in between
- 15 May 20263 of 3 present3 independent · 49 days in between
- 26 Mar 20263 of 3 present3 independent · 14 days in between
- 11 Mar 20263 of 3 present3 independent · 32 days in between
1 earlier meeting
- 6 Feb 20263 of 3 present3 independent
Nomination and remuneration committee
Chair Ratna Kishore Kaza
Venkata Ramudu Jasthi, Prameela Rani Yalamanchili
- 15 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Ratna Kishore Kaza
Bhaskara Rao Bollineni, Adwik Bollineni
- 31 Mar 20263 of 3 present1 independent · 53 days in between
Risk Management Committee
Chair Prameela Rani Yalamanchili
Saumen Chakraborty, Abhinay Bollineni, Anitha Dandamudi
- 5 Feb 20263 of 4 present2 independent
Corporate Social Responsibility Committee
Chair Bhaskara Rao Bollineni
Anitha Dandamudi, Ratna Kishore Kaza
No meeting listed in the filing.
Finance and Investment Committee
Chair Saumen Chakraborty
Bhaskara Rao Bollineni, Prameela Rani Yalamanchili, Suresh Natwarlal Patel
No meeting listed in the filing.
IT Steering Committee
Chair Saumen Chakraborty
Abhinay Bollineni, Ratna Kishore Kaza
No meeting listed in the filing.
FINANCE & INVESTMENT COMMITTEE
- 19 Jun 20263 of 4 present2 independent
- 19 Jun 20263 of 4 present2 independent · 2 days in between
- 16 Jun 20263 of 4 present2 independent · 2 days in between
- 13 Jun 20264 of 4 present3 independent · 93 days in between
2 earlier meetings
- 11 Mar 20264 of 4 present3 independent · 32 days in between
- 6 Feb 20264 of 4 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- S.R. BATLIBOI & ASSOCIATES LLPPeer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Krishna Institute of Medical Sciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Krishna Institute of Medical Sciences share news and announcements
Annual general meeting, 27 Aug 2026
97,610 shareholders on the register on 20 Aug 2026; present: 2 promoters and 69 others; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
To consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditor’s thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 84.89% · promoters 99.77% · institutions 91.40% · other public 42.61%
- To appoint Ms. Dandamudi Anitha, (DIN: 00025480), who retires by rotation and being eligible, offers herself for re-appointment as a Director.Ordinary74.46% for25.54% against
Against: promoters 0.00% · institutions 49.49% · other public 0.00%
Turnout: all 83.66% · promoters 99.77% · institutions 88.86% · other public 42.61%
- To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2026-27Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 84.90% · promoters 99.77% · institutions 91.40% · other public 42.61%
- Approval for granting loans / giving guarantees or providing securities under section 185 of the Companies Act, 2013.Special78.38% for21.62% against
Against: promoters 0.00% · institutions 41.32% · other public 0.00%
Turnout: all 84.90% · promoters 99.77% · institutions 91.40% · other public 42.61%
- To Approve the overall limits u/s 186 for Loans/ Guarantees/ Securities/ Investments by the CompanySpecial78.50% for21.50% against
Against: promoters 0.00% · institutions 41.09% · other public 0.00%
Turnout: all 84.89% · promoters 99.77% · institutions 91.40% · other public 42.61%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 9 Jul 2026, 2 resolutions
98,093 shareholders on the register on 2 Jul 2026; present: 3 promoters and 54 others; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
Issue of 77,02,182 (Seventy-Seven Lakh Two Thousand One Hundred and Eighty-Two) Warrants, each fully convertible into or exchangeable for 1 (One) fully paid-up equity share of ₹2/- (Indian Rupees Two) each, on a preferential basis to Dr. Abhinay Bollineni (Promoter), Mr. Adwik Bollineni (Promoter) and Bharas Ventures LLP (a Promoter Group entity)MoreLess
SpecialPromoters have an interest in it94.32% for5.68% againstAgainst: promoters 0.00% · institutions 9.63% · other public 0.00%
Turnout: all 75.41% · promoters 80.08% · institutions 90.43% · other public 26.95%
- Change of designation of Mr. Adwik Bollineni (DIN: 06549059) from Non-Executive Director to Executive Director of the Company for a period of 5 (Five) years with effect from 15 May 2026OrdinaryPromoters have an interest in it82.32% for17.68% against
Against: promoters 0.00% · institutions 19.65% · other public 0.00%
Turnout: all 49.39% · promoters 0.00% · institutions 90.43% · other public 26.95%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 15 Apr 2026, 1 resolution
94,813 shareholders on the register on 13 Mar 2026; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
- Issuance of equity shares to investors by way of a qualified institutions placement for raising of funds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 70.90% · promoters 81.10% · institutions 87.39% · other public 10.93%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 1 Feb 2026, 1 resolution
1,01,551 shareholders on the register on 30 Dec 2025; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
- Approval of Material Related Party Transaction with KIMS Hospital Bengaluru Private Limited, Subsidiary Company.Ordinary93.18% for6.82% against
Against: promoters 0.00% · institutions 12.75% · other public 0.00%
Turnout: all 79.61% · promoters 81.10% · institutions 90.54% · other public 49.64%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Aug 2025, 4 resolutions
1,04,017 shareholders on the register on 22 Aug 2025; present: 3 promoters and 57 others; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditor’s thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 78.23% · promoters 80.91% · institutions 91.20% · other public 41.03%
- To appoint Dr. Abhinay Bollineni, (DIN No. 01681273), who retires by rotation and being eligible, offers himself for re-appointment as a Director.OrdinaryPromoters have an interest in it96.25% for3.75% against
Against: promoters 0.00% · institutions 6.80% · other public 0.00%
Turnout: all 78.23% · promoters 80.91% · institutions 91.20% · other public 41.03%
- To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2025-26.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 78.23% · promoters 80.91% · institutions 91.20% · other public 41.03%
- Appointment of M/s IKR & Associates, Practising Company Secretaries, as the Secretarial Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 78.23% · promoters 80.91% · institutions 91.20% · other public 41.03%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Jul 2025, 1 resolution
1,10,520 shareholders on the register on 20 Jun 2025; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
- Re-appointment of Ms. Prameela Rani Yalamanchili (DIN: 03270909) as an Independent Director of the Company for a second term of five yearSpecial95.66% for4.34% against
Against: promoters 0.00% · institutions 6.49% · other public 0.03%
Turnout: all 64.43% · promoters 50.38% · institutions 91.19% · other public 14.20%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 16 Mar 2025, 1 resolution
1,13,875 shareholders on the register on 7 Feb 2025; votes counted by Krishna Rao Inturi / IKR & Associates.The company's voting result (opens in a new tab)
- Appointment of Mr. Suresh Natwarlal Patel (DIN No. 07202263) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.72%
Turnout: all 76.96% · promoters 87.67% · institutions 90.43% · other public 0.19%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Aug 2024, 7 resolutions
Present: 2 promoters and 55 others.The company's voting result (opens in a new tab)
1. To consider and adopt (a) the audited standalone financial statements of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and the Auditors thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2024 and the report of Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 86.29% · promoters 98.71% · institutions 89.76% · other public 29.29%
- 2 - To appoint Dr. Bhaskara Rao Bollineni, (DIN No. 00008985), who retires by rotation and, being eligible, offers himself for re-appointment as a Director.OrdinaryPromoters have an interest in it99.83% for0.17% against
Against: promoters 0.00% · institutions 0.20% · other public 0.00%
Turnout: all 54.08% · promoters 15.73% · institutions 89.76% · other public 26.58%
- 3 - To re-appoint M/s. S.R. Batliboi & Associates, Statutory Auditors from the conclusion of this Annual General Meeting until the conclusion of the Twenty-Seventh Annual General MeetingOrdinary99.70% for0.30% against
Against: promoters 0.00% · institutions 0.58% · other public 0.00%
Turnout: all 86.29% · promoters 98.71% · institutions 89.76% · other public 29.29%
- 4 - To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2024-25.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 86.29% · promoters 98.71% · institutions 89.76% · other public 29.29%
- 5 - Approval of Re-classification of persons from “Promoter Group Category” to “Public Category”.OrdinaryPromoters have an interest in it99.20% for0.80% against
Against: promoters 0.00% · institutions 0.99% · other public 0.00%
Turnout: all 55.76% · promoters 20.20% · institutions 89.76% · other public 26.22%
6 - Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 86.33% · promoters 98.71% · institutions 89.76% · other public 29.65%
- 7 - Alteration of Capital Clause (Clause V) of the Memorandum of Association of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 86.29% · promoters 98.71% · institutions 89.76% · other public 29.29%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 27 Aug 2026, 14 fund houses so far (houses' deadline to file 15 Oct 2026)
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditor’s thereonMoreLess
14 for0 against- To appoint Ms. Dandamudi Anitha, (DIN: 00025480), who retires by rotation and being eligible, offers herself for re-appointment as a Director.
Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundNon-disclosure of details as required under section 36(3) of SEBI (LODR) Regulations, 2015. Governance concern: Inadequate disclosures as per requirement under SS-2; Low board meeting attendance during FY26 and in previous FYs also.
- DSP Mutual Fund, Jio BlackRock Mutual FundMs. Dandamudi Anitha, 57, is Executive Director (Operations) since March 2008. She has attended 56% (5 out of 9) board meetings held in FY26 and 74% (20 out of 27) board meetings in the last three financial years. We expect directors to attend all board meetings: we have a threshold of 75% attendance of the board meetings in the three-years prior to re-appointment. While her reappointment is in line with statutory regulations, we are unable to support the reappointment given her low attendance. We do not support the resolution.
- Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNon-compliance: Non-disclosure of details as required under section 36(3) of SEBI (LODR) Regulations, 2015. Governance concern: Inadequate disclosures as per requirement under SS-2; Low board meeting attendance during FY26 and in previous FYs also.
- ICICI Prudential Mutual FundMs. Dandamudi Anitha, 57, is Executive Director (Operations) since March 2008. She has attended 56% (5 out of 9) board meetings held in FY26 and 74% (20 out of 27) board meetings in the last three financial years. While her reappointment is in line with statutory regulations, given her low attendance the AMC has voted against the resolution.
7 for7 against - To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2026-2714 for0 against
- Approval for granting loans / giving guarantees or providing securities under section 185 of the Companies Act, 2013.
Against DSP Mutual Fund, Jio BlackRock Mutual Fund
- DSP Mutual Fund, Jio BlackRock Mutual FundThe company seeks shareholder approval to provide loans, guarantees and security upto Rs. 6.5 bn over and above the automatic limits, to a subsidiary or associate or joint venture or any group entity of the company or any other person in which any of the directors of the company are deemed to be interested. While the resolution is enabling in nature, it also allows financial support to entities in which directors are interested, including promoter companies. Further, the proposed limit is structured as a rolling limit linked to the company’s net worth; we do not support such rolling limits. The company must seek approval for an absolute limit. The company should also have provided clarity on the specific entities involved, the nature of the company’s interest, and the rationale for extending such support. In the absence of disclosures, we do not support the resolution.
2 for2 against - To Approve the overall limits u/s 186 for Loans/ Guarantees/ Securities/ Investments by the Company
Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, Quantum Mutual Fund
- Angel One Mutual FundGovernance & Transparency Concern: Lack of adequate disclosure as the Company has not provided details of the recipients. Umbrella / Blanket approval proposed to cover any person/entity in the proposed limit.
- DSP Mutual Fund, Jio BlackRock Mutual FundAs on 31 March 2026 the company had made investments/granted loans and provided guarantees of ~Rs. 9.0 bn (including investment/granted loans outstanding) under Section 186. The company should clearly disclose the extent of limits utilized under Section 186 for FY26 in the meeting notice. Further, this is an enabling approval, and it allows the company to give loans/ guarantees/ provide securities to anybody corporate, including promoter group companies. Further, the proposed limit is structured as a rolling limit linked to the company’s net worth; we do not support such rolling limits. The company must seek approval for an absolute limit. We believe the company must disclose granular details, including the names of the companies, the nature and size of their operations, and the terms of support, to enable shareholders to make an informed decision. Given the lack of clarity, we do not support the resolution.
- Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with the law. Governance & Transparency Concern: Lack of adequate disclosure as the Company has not provided details of the recipients. Umbrella / Blanket approval proposed to cover any person/entity in the proposed limit.
- Quantum Mutual FundThe company seeks approval to provide loans, guarantees, and security of up to Rs. 6.5 billion over and above the automatic limits under section 186. This is an enabling approval, and it allows the company to give loans/ guarantees/ provide securities to anybody corporate, including promoter group companies. However, the company has not provided sufficient details on the extent of limits utilized under Section 186 or the specific entities that may benefit from the proposed enabling approval. Further, the proposed limit is structured as a rolling limit linked to the company’s net worth rather than an absolute limit. In the absence of adequate disclosures on the beneficiaries, nature and size of their operations, and terms of support, we do not support the resolution.
6 for7 against
2 proposals not matched to one resolution
To (a) give any loan to any person or other body corporate (b) give any guarantee or provide security in connection with a loan to any other body corporate or person; and (c) acquire by way of subscription, purchase or otherwise, the securities of any other body corporate, up to an aggregate amount not exceeding Rs. 650 Cr over and above the limit of 60% of the paid-up share capital, free reserves and securities premium account of the Company or 100% of free reserves and securities premium account of the Company, whichever is higher, available to the Company from time to time under Section 186 and other applicable provisions of the Act.MoreLess
1 for0 againstTo give loan including any loan represented by a book debt, or give any guarantee or provide any security in connection with any loan taken by any entity which is a subsidiary or associate or joint venture or group entity of the Company in which any director is deemed to be interested as specified in the explanation to sub-section 2 of Section 185 of the Act up to a sum not exceeding Rs. 650 Cr over and above the limits available to the Company under Section 186 and other applicable provisions of the Act, which is in its absolute discretion deem beneficial and in the best interest of the Company.MoreLess
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, Quantum Mutual Fund
- Angel One Mutual FundInadequate disclosures with regards to the particulars mandated u/s 185 of Companies Act, 2013. Governance Concern: Enabling Approval with Inadequate disclosures – Generic justification and non-disclosure of the recipient(s) of the investments, loans, guarantees and security.
- Edelweiss Mutual Fund, Navi Mutual FundNon-Compliant with Section 185 of the Companies Act: Inadequate disclosures w.r.t. the particulars mandated u/s 185 of Companies Act, 2013. Governance Concern: Enabling Approval with Inadequate disclosures – Generic justification and non-disclosure of the recipient(s) of the investments, loans, guarantees and security.
- PGIM India Mutual FundNon-Compliant with Section 185 of the Companies Act: Inadequate disclosures w.r.t. the particulars mandated u/s 185 of Companies Act, 2013. Governance Concern: Enabling Approval with Inadequate disclosures Generic justification and non-disclosure of the recipient(s) of the investments, loans, guarantees and security.
- Quantum Mutual FundThe company seeks approval to provide loans, guarantees, and security of up to Rs. 6.5 billion over and above the automatic limits under section 185 to a subsidiary or associate or joint venture or any group entity of the company or any other person in which any of the directors of the company are deemed to be interested. However, the proposal does not provide sufficient details on the specific entities that may benefit, the company’s economic interest in such entities, or the rationale and need for extending such financial assistance. Further, the proposed limit is structured as a rolling limit rather than an absolute limit. Given the lack of clarity on the beneficiaries, purpose, and basis for extending such support, as well as the absence of adequate disclosures, we do not support the resolution.
5 for5 against
Mutual fund votes, meeting of 9 Jul 2026, 14 fund houses so far (houses' deadline to file 15 Oct 2026)
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
Issue of 77,02,182 (Seventy-Seven Lakh Two Thousand One Hundred and Eighty-Two) Warrants, each fully convertible into or exchangeable for 1 (One) fully paid-up equity share of ₹2/- (Indian Rupees Two) each, on a preferential basis to Dr. Abhinay Bollineni (Promoter), Mr. Adwik Bollineni (Promoter) and Bharas Ventures LLP (a Promoter Group entity)MoreLess
1 for0 against- Change of designation of Mr. Adwik Bollineni (DIN: 06549059) from Non-Executive Director to Executive Director of the Company for a period of 5 (Five) years with effect from 15 May 2026
Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundGovernance concern: Skewed remuneration practicestowards promoter Executive Directors.
- DSP Mutual FundAdwik Bollineni, 34, is part of the promoter group and the son of the Chairperson & Managing Director, Dr. Bhaskar Rao Bollineni. He has served as a non-executive non-independent director since 28 November 2023 and oversees the operations of the Andhra units. He attended six of the nine board meetings (67%) held in FY26 and 16 of the 20 board meetings (80%) held since his appointment. We expect directors to attend all board meetings. The company proposes to redesignate him as Executive Director. Based on the proposed terms, we estimate his annual remuneration at Rs. 12.5 mn, which is in line with peers and commensurate with the size and complexity of the business. His variable pay is capped at Rs. 4.0 mn p.a., however, the company should disclose the performance parameters that determine the variable pay. We note that he is also the CEO of Servejana Healthcare Private Limited (KIMS Sunshine), a 56.6% subsidiary of the company. As clarified by the company, he serves in this role on a pro bono basis without remuneration and will step down as he assumes executive responsibilities for the Andhra Pradesh cluster. The company has also stated that he has been associated with the operations and management of various KIMS Group hospitals for several years in an informal, unpaid capacity. However, it has not been demonstrated that he meets the minimum ten years of relevant post-qualification work experience required under our voting policy. In the absence of clarity regarding minimum post qualification relevant work experience. We do not support the resolution.
- Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. No concern with the proposed re-designation per-se. Governance concern: Skewed remuneration practices towards promoter EDs.
- ICICI Prudential Mutual FundMr. Adwik Bollineni has moderate board attendance, inadequate disclosure of variable‑pay performance and his remuneration would be exceeding that of a more experienced non‑promoter executive. Due to these concerns, the AMC has voted against the resolution.
- Jio BlackRock Mutual FundAdwik Bollineni, 34, is part of the promoter group and the son of the Chairperson & Managing Director, Dr. Bhaskar Rao Bollineni. He has served as a non-executive non-independent director since 28 November 2023 and oversees the operations of the Andhra units. He attended six of the nine board meetings (67%) held in FY26 and 16 of the 20 board meetings (80%) held since his appointment. We expect directors to attend all board meetings. The company proposes to redesignate him as Executive Director. Based on the proposed terms, we estimate his annual remuneration at Rs. 12.5 mn, which is in line with peers and commensurate with the size and complexity of the business. His variable pay is capped at Rs. 4.0 mn p.a., however, the company should disclose the performance parameters that determine the variable pay. We note that he is also the CEO of Servejana Healthcare Private Limited (KIMS Sunshine), a 56.6% subsidiary of the company. It is unclear whether he currently draws, or will draw, remuneration from this subsidiary. Consequently, we are unable to assess his aggregate remuneration from the KIMS group, which may be higher than the remuneration paid to the professional executive director. Further, based on his public profile he has less than ten years of post-qualification work experience and his appointment is not in line with our voting policy. In the absence of clarity regarding his aggregate remuneration from the company and its subsidiaries and minimum post qualification relevant work experience. We do not support the resolution.
7 for7 against
3 proposals not matched to one resolution
- 1) Approve preferential issue of 7.7 mn warrants convertible into equity shares to promoter and promoter group at a price of Rs. 779.0 per warrant aggregating to Rs. 6.0 bn.1 for0 against
- Approve preferential issue of 7.7 mn warrants convertible into equity shares to promoter and promoter group at a price of Rs. 779.0 per warrant aggregating to Rs. 6.0 bn2 for0 against
To create, offer, issue and allot from time to time in one or more tranches, 77,02,182 warrants, each convertible into, or exchangeable for, 1 fully paid-up equity share of the Company of face value of Rs. 2/- each (Warrants) at a price of Rs. 779.00/- (including a premium of Rs. 777.00/- each) being not less than the higher of the floor price determined in accordance with the provisions of Chapter V of the SEBI ICDR Regulations and the provisions of the Articles of Association of the Company, (i.e., basis the price determined by the valuation report of a registered valuer) each, payable in cash (Warrants Issue Price), aggregating to Rs 5,99,99,99,778/-.MoreLess
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, Quantum Mutual Fund
- Angel One Mutual FundGovernance concern: Warrants priced at par with equity shares. Shares and warrants are two different species of securities. Excessive potential dilution within a period of less than 12 months, and no clarity regarding the reason behind not opting for the Rights Issue. Transparency Concern: The Company has not provided sufficient justification for allotment to the promoter and why the warrants were issued.
- Edelweiss Mutual Fund, Navi Mutual FundCompliant with the law. Governance concern: Warrants priced at par with equity shares. Shares and warrants are two different species of securities. Excessive potential dilution within a period of less than 12 months, and no clarity regarding the reason behind not opting for the Rights Issue. Transparency Concern: The Company has not provided sufficient justification for allotment to the promoter and why the warrants were issued.
- Quantum Mutual FundThe approval is to issue 7.7 million warrants to promoters at Rs. 779 each, raising about Rs. 6.0 billion, with a potential dilution of 1.9% for existing shareholders. The proceeds will support debt repayment, investments, and general corporate purposes of the company. We note that the D/E of company stands at 1.04 at consolidated level. We do not support the proposed warrant issue. Warrants allow promoters to subscribe to shares within 18 months by paying only 25% upfront, with the balance payable on exercise. As the exercise price is fixed at the current issue price, promoters benefit from any upside while limiting their downside to the upfront payment. Further, the company has not explained why it chose a warrant issue over alternatives such as a preferential allotment or a rights issue. In the absence of a clear rationale, we do not favor the resolution.
6 for4 against
6 earlier meetings
Mutual fund votes, meeting of 15 Apr 2026, 28 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- Issuance of equity shares to investors by way of a qualified institutions placement for raising of funds.27 for0 against
1 proposal not matched to one resolution
- Grants the Board flexibility to raise ₹1,500 crore via QIP to support growth and capital requirements, within SEBI safeguards1 for0 against
Mutual fund votes, meeting of 1 Feb 2026, 24 fund houses
- Approval of Material Related Party Transaction with KIMS Hospital Bengaluru Private Limited, Subsidiary Company.
Against Angel One Mutual Fund, Bank of India Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Invesco Mutual Fund, Jio BlackRock Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundNon-disclosure of required information as per the Related Party Transaction Industry Standards. Transparency concern: Non-disclosure of conflict of interest of directors/ KMPs/ their relatives in the explanatory statement.
- Bank of India Mutual Fund, Jio BlackRock Mutual FundKIMS Hospital Bengaluru Private Limited (KHBPL), incorporated in 2017, is an 80% subsidiary of Krishna Institute of Medical Sciences (KIMS). Curo Hospital Bangalore Private Limited holds the residual 20% of KHBPL. KHBPL is engaged in the establishment and operation of multi-specialty tertiary healthcare facilities in Bengaluru. It commenced operations at two newly established multi-specialty tertiary care hospitals in FY26 and is currently in the early stages of scaling up. The proposed transaction is for extending loans not exceeding Rs. 1.5 bn to KHBPL, a subsidiary company. The company intends to provide financial assistance to KHBPL to meet its working capital requirements and additional capital expenditure needs, as the subsidiary has recently commenced operations. The financial support is expected to help KHBPL accelerate operational scale-up, enhance network and expand clinical offerings. The proposed loan will carry an interest rate of 12% p.a., which the company states is 4% points above its average return on investments, and a moratorium of one year on principal and interest payments followed by a repayment period of five years. KIMS will source its funds from internal accruals and borrowings. However, it is unclear if the financial support rendered to KHBPL will be to the extent of KIMS’ shareholding and the balance will be contributed by the other 20% shareholder Curo Hospitals. In the absence of clarity, we are unable to support the resolution.
- Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNon-Compliant with RPT Industry Standards: Non-disclosure of required information as per the RPT Industry Standards mandated by SEBI. Transparency concern: Non-disclosure of conflict of interest of directors/ KMPs/ their relatives in the explanatory statement.
- ICICI Prudential Mutual FundKIMS Hospital Bengaluru Private Limited (KHBPL), incorporated in 2017, is an 80% subsidiary of Krishna Institute of Medical Sciences (KIMS). Curo Hospital Bangalore Private Limited holds the residual 20% of KHBPL. KHBPL is engaged in the establishment and operation of multi-specialty tertiary healthcare facilities in Bengaluru. It commenced operations at two newly established multi-specialty tertiary care hospitals in FY26 and is currently in the early stages of scaling up. The proposed transaction is for extending loans not exceeding Rs. 1.5 bn to KHBPL, a subsidiary company. The company intends to provide financial assistance to KHBPL to meet its working capital requirements and additional capital expenditure needs, as the subsidiary has recently commenced operations. The financial support is expected to help KHBPL accelerate operational scale-up, enhance network and expand clinical offerings. The proposed loan will carry an interest rate of 12% p.a., which the company states is 4% points above its average return on investments, and a moratorium of one year on principal and interest payments followed by a repayment period of five years. KIMS will source its funds from internal accruals and borrowings. However, it is unclear if the financial support rendered to KHBPL will be to the extent of KIMS’ shareholding and the balance will be contributed by the other 20% shareholder Curo Hospitals. In the absence of clarity on obligations/contributions of 20% shareholders, we propose to vote against the resolution.
- Invesco Mutual FundKIMS Hospital Bengaluru Private Limited (KHBPL), incorporated in 2017, is an 80% subsidiary of Krishna Institute of Medical Sciences (KIMS). Curo Hospital Bangalore Private Limited holds the residual 20% of KHBPL. KHBPL is engaged in the establishment and operation of multi-specialty tertiary healthcare facilities in Bengaluru. It commenced operations at two newly established multi-specialty tertiary care hospitals in FY26 and is currently in the early stages of scaling up. The proposed transaction is for extending loans not exceeding Rs. 1.5 bn to KHBPL, a subsidiary company. The company intends to provide financial assistance to KHBPL to meet its working capital requirements and additional capital expenditure needs, as the subsidiary has recently commenced operations. The financial support is expected to help KHBPL accelerate operational scale-up, enhance network and expand clinical offerings. The proposed loan will carry an interest rate of 12% p.a., which the company states is 4% points above its average return on investments, and a moratorium of one year on principal and interest payments followed by a repayment period of five years. KIMS will source its funds from internal accruals and borrowings. However, it is unclear if the financial support rendered to KHBPL will be to the extent of KIMS’ shareholding and the balance will be contributed by the other 20% shareholder Curo Hospitals. The company must clarify the reason for the discrepancy between the reported RPT in the Annual Report and the postal ballot notice. In the absence of clarity, we are unable to support the resolution
14 for10 against
Mutual fund votes, meeting of 29 Aug 2025, 28 fund houses
To receive, consider and adopt the audited standalone and consolidated financial statements of the Company for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditor’s thereon.MoreLess
28 for0 against- To appoint Dr. Abhinay Bollineni, (DIN No. 01681273), who retires by rotation and being eligible, offers himself for re-appointment as a Director.
Against Angel One Mutual Fund, Capitalmind Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
- Angel One Mutual FundNon-disclosure of details as per legal requirements; Skewed remuneration practice in favour of Promoter Directors
- Capitalmind Mutual Fund, Groww Mutual Fund, Navi Mutual FundNon-compliance: Non-disclosure of details as required under section 36(3) of SEBI (LODR) Regulations, 2015. Governance concern: Skewed remuneration practice in favor of Promoter Directors & Inadequate disclosures as per requirement under SS-2.
- Motilal Oswal Mutual FundGovernance concern: Skewed remuneration practice in favor of Promoter Directors & Inadequate disclosures as per requirement under SS-2.
23 for5 against - To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2025-26.28 for0 against
- Appointment of M/s IKR & Associates, Practising Company Secretaries, as the Secretarial Auditors of the Company28 for0 against
Mutual fund votes, meeting of 23 Jul 2025, 25 fund houses
- Re-appointment of Ms. Prameela Rani Yalamanchili (DIN: 03270909) as an Independent Director of the Company for a second term of five year
Against Angel One Mutual Fund, Bank of India Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundPrior approval of shareholders not sought for re-appointment as an Independent Director. Transparency Concern: No clarity on whether proposed appointee holds non-independent positions in group companies.
- Bank of India Mutual Fund, Edelweiss Mutual Fund, Motilal Oswal Mutual FundNo concern on the merit of proposed appointee. Non-Compliant with Companies Act: Prior approval of shareholders not sought for re-appointment as an ID.
- Groww Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNo concern on the merit of proposed appointee. Non-Compliant with Companies Act: Prior approval of shareholders not sought for re-appointment as an ID. Transparency Concern: No clarity on whether proposed appointee holds non-independent positions in group companies.
- Nippon India Mutual FundNon-Compliant with Companies Act: Prior approval of shareholders not sought for re-appointment as an ID.
17 for8 against
Mutual fund votes, meeting of 16 Mar 2025, 22 fund houses
- Appointment of Mr. Suresh Natwarlal Patel (DIN No. 07202263) as an Independent Director of the Company22 for0 against
Mutual fund votes, meeting of 29 Aug 2024, 18 fund houses
1. To consider and adopt (a) the audited standalone financial statements of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and the Auditors thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2024 and the report of Auditors thereon.MoreLess
18 for0 against- 2 - To appoint Dr. Bhaskara Rao Bollineni, (DIN No. 00008985), who retires by rotation and, being eligible, offers himself for re-appointment as a Director.
Against Groww Mutual Fund, Motilal Oswal Mutual Fund
- Groww Mutual Fund, Motilal Oswal Mutual FundRe-appointment Compliant with law. Governance concern: Holds dual position of Chairman and Managing Director and Skewed remuneration practice.
16 for2 against - 3 - To re-appoint M/s. S.R. Batliboi & Associates, Statutory Auditors from the conclusion of this Annual General Meeting until the conclusion of the Twenty-Seventh Annual General Meeting
Against Groww Mutual Fund
- Groww Mutual FundNon-Compliant with Regulation 36(5) of SEBI LODR: Proposed audit fee of auditors not disclosed.
17 for1 against - 4 - To ratify the remuneration payable to the Cost Auditors, M/s. Sagar & Associates, for the financial year 2024-25.18 for0 against
- 5 - Approval of Re-classification of persons from “Promoter Group Category” to “Public Category”.
Against Edelweiss Mutual Fund, Groww Mutual Fund
- Edelweiss Mutual FundPotential for conflict of interest and minority shareholder interest can be diluted.
- Groww Mutual FundNon-Compliance: Promoters seeking re-classification do not fulfil the criteria as per Regulation 31A of the SEBI LODR. Governance Concern: Disguised Re-classification proposed.
16 for2 against 6 - Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up.MoreLess
18 for0 against- 7 - Alteration of Capital Clause (Clause V) of the Memorandum of Association of the Company.18 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Stakes in unlisted companies
Reported in the filing for the quarter to Jun 2026.
- Unlisted stake boughtArunodaya Hospitals Private LimitedSince 14 Feb 2026
2.09% bought in the quarter; holding 65.95%, from 63.86%
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere | Reason and comments |
|---|---|---|---|---|---|---|
| Preferential IssuesJun 2026, checked by CARE Ratings Limited | 1,500.00 | Repayment and/or prepayment of certain outstanding borrowings, in full or part, availed by KIMS | 910.00 | 910.00 | No | Audit committee: The Audit Committee in its meeting held on 3rd August, 2026, noted that there is NIL deviation or variation in the utilisation of funds raised from the objects stated in the offer document. |
| Preferential IssuesJun 2026, checked by CARE Ratings Limited | 1,500.00 | Investment into certain Subsidiaries, namely Chalasani Hospitals Pvt Ltd, KIMS Hospitals Pvt Ltd and KIMS Hospital Bengaluru Pvt Ltd, for repayment or prepayment, in full or in part, of certain outstanding borrowings availed by such Subsidiaries | 215.00 | 130.00 | No | Audit committee: The Audit Committee in its meeting held on 3rd August, 2026, noted that there is NIL deviation or variation in the utilisation of funds raised from the objects stated in the offer document. |
| Preferential IssuesJun 2026, checked by CARE Ratings Limited | 1,500.00 | General Corporate Purposes | 351.45 | 44.00 | No | Audit committee: The Audit Committee in its meeting held on 3rd August, 2026, noted that there is NIL deviation or variation in the utilisation of funds raised from the objects stated in the offer document. |
| Preferential IssuesJun 2026, checked by CARE Ratings Limited | 1,500.00 | Issue Expenses | 23.55 | 2.49 | No | Audit committee: The Audit Committee in its meeting held on 3rd August, 2026, noted that there is NIL deviation or variation in the utilisation of funds raised from the objects stated in the offer document. |